3i has backed the buyout of Active Pharmaceuticals Ingredients, an Oslo-based supplier and developer of pharmaceutical ingredients and division of NYSE-listed Alpharma Inc, for $395m.
Laura Clayfield and Raj Mukherji have joined the London-based mid-market sponsor
Eurazeo and Unigestion among LPs in new fund for industrial tech businesses Raith and AEMtec
BlackRock mulls new vintage of private capital products for sophisticated retail investors in Europe
Global asset manager explores new generation of private market funds for wealthy individuals banking on positive uptake from retail investors
Despite macro woes, sponsor wants to build up on last year’s pace of investment and exceed GBP 400m mark in 2023